Michael S. Davis, MD, provides a brief history of transplant surgery, discusses the indications for renal autotransplant, and reviews proper surgical techniques for this procedure. He also stresses the importance of coordinating with the transplant and vascular surgery team for success in these cases.
Read More
Samit D. Soni, MD, reviews the contemporary algorithm for the management of retroperitoneal fibrosis (RPF) in 2018. He discusses imaging, specific medical and surgical approaches, as well as operative advice for minimally-invasive surgery for RPF.
Read More
Richard E. Link, MD, PhD, provides guidance for urologic surgeons in the management of autosomal dominant polycystic kidney disease (ADPKD). He discusses relevant literature, patient selection, and he efficacy and safety for laparoscopic cyst decortication, and operative advice for handling massive kidneys during minimally invasive surgery.
Read More
Wesley A. Mayer, MD, reviews the landmark trials that set the standard of care for cytoreductive nephrectomy (CN) and the impact of targeted therapy on this technique. He discusses recent clinical trials on CN and targeted therapy, as well as data regarding cytoreductive partial nephrectomy.
Read More
Michael S. Davis, MD, reviews the historic shift from radical retropubic prostatectomy (RPP) to a robotic technique dominating practice trends. He discusses the influence of marketing and industry on this trend, as well as cost and outcome benefits of both techniques.
Read More
Wesley A. Mayer, MD, presents a framework for diagnosis and treatment of chronic flank pain, identifying common and uncommon causes. He discusses papillary calcifications, Loin Pain Hematuria Syndrome, polycystic kidney disease, and treatment approaches such as renal denervation and renal autotransplant.
Read More
Richard E. Link, MD, PhD, discusses current challenges in the management of renal cell carcinoma (RCC), as well as research efforts to address these challenges. He specifically reviews 3D-printed models and virtual reality simulation for pre-surgical rehearsal and training, and an engineered animal model for identifying genetic targets in papillary RCC.
Read More
John W. Davis, MD, provides instructions regarding how to build an effective handout for patients prior to robot assisted radical prostatectomy. Specifically, he describes commonly asked patient questions and how to answer in an evidence-based and trustworthy manner.
Read More
Jeffrey A. Jones, MD, argues that although radical therapy leads to better oncological control than focal therapy, focal therapy may be more appropriate for certain prostate cancer patients in order to mitigate adverse effects. He examines oncological and quality of life outcomes of localized therapies, specifically cryotherapy and high-intensity focused ultrasound (HIFU).
Read More
John W. Davis, MD, discusses the benefits and limitations of focal therapy for prostate cancer. He describes ways in which focal therapy can be a middle ground between active surveillance and standard therapies, as well as identifying appropriate candidates for this approach.
Read More
Guilherme Godoy, MD, MPH, details the controversies surrounding the evolving United States Preventive Services Task Force (USPSTF) recommendations on PSA screening. He then emphasizes the need for individualizing risk assessment in clinical decisions-making for prostate cancer.
Read More
Dov Kadmon, MD, discusses the role of MRI in the diagnosis, staging, and surveillance of prostate cancer. He then reviews two high quality studies that evaluate the possibility of MRI guided biopsies as an alternative to standard ultrasound biopsies.
Read More
